Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

The Prebiotic Effect of Daily Intake of Orange Juice Affects the Bioavailability of Flavanones?

25. april 2017 opdateret af: Thais Cesar, São Paulo State University

Influence of the Prebiotic Effect of Orange Juice on the Bioavailability of Flavanones After Chronic Intake of Orange Juice.

This study aimed investigate the chronic effect of orange juice consumption on gut microbiota and in the bioavailability of flavanones and metabolites by feces, blood and urine analysis.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Non-randomized study with interrupted time series and open-label, in which women were enrolled and advised to not consumed foods containing prebiotic, probiotic and fibers, and citrus fruits and beverages during 30 days before of intervention (n=10; BMI 23.8 kg/m2; 28 years). After 30 days, the participants will consume during 60 days 300 mL of orange juice daily. After 60 days of orange juice intervention, the participants will be submitted to 30 days of washout. Samples of blood, urine and feces will collect in five different occasions (baseline, 30 day, 60 day, 90 day, and 120 day) in order to evaluate the prebiotic effect of orange juice on gut microbiota and in the bioavailability of its flavanones. The recruitment process began in September 2016 and the intervention was carried out from October 2016 to February 2017, and the data analysis will start in February 2017. The sample number took into account variances on blood hesperitin levels with a type I error α = 0.05 and a type II error β = 0.2 (80% power) (Silveira et al., 2015). The minimum sample size should have six individuals into the same group. Considering an approximately 15% dropout rate, the final sample size of study was constituted by 10 women. Primary endpoint is the changes in total bacteria population (Lactobacillus spp., Bifidobacterium spp., and reduction of Clostridium spp.) that can result in increased of butyric, acetic, and propionic acid concentrations, and reduction of ammonium production. Secondary endpoint is enhancement of bioavailability of flavanones (hesperitin, naringenin) and metabolites in the blood, urine and feces. Kolmogorov Smirnov and Levene test will be used to assess the normality and homogeneity of data, respectively. One-way analysis of variance (ANOVA) will be apply to determine the intervention effect over the time 0, 30 day, 60 day, 90 day, and 120 day). P significance was set up ≤ 0.05.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

10

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Sao Paulo
      • Araraquara, Sao Paulo, Brasilien, 14800-903
        • Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 55 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Kvinde

Beskrivelse

Inclusion Criteria:

Healthy women BMI 18.5 - 29.9 kg/m2.

Exclusion Criteria:

Gastrointestinal diseases Pregnant women Regular use of medications Dietary restrictions, vegetarian diet, macrobiotic, etc. Use of vitamins or dietary supplements Use of probiotics or prebiotics in the last 3 months and antibiotics in the last 6 months.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Grundvidenskab
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Orange juice
Ten women will consume 100% orange juice (300 mL/day) during 60 days.
Thirty days before the beginning of trial, women (n= 10; BMI 23.8 kg/m2; 28 years) will be advised to not consumed foods containing prebiotic, probiotic and fibers, and citrus fruits and beverages. After 30 days, the participants will consume 300 mL of orange juice daily during 60 days. After 60 days of orange juice intervention, the participants will be submitted to 30 days of washout. Samples of blood, urine and feces will collect in five different occasions (baseline, 30 day, 60 day, 90 day, and 120 day) in order to evaluate the prebiotic effect of orange juice on gut microbiota and the bioavailability of its flavanones in blood, urine and feces.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
Total counting of aerobic bacteria and facultative anaerobic bacteria
Tidsramme: 4 months
4 months
Determination of butyric acid
Tidsramme: 4 months
4 months
Determination of acetic acid
Tidsramme: 4 months
4 months
Ammonium concentration
Tidsramme: 4 mounths
4 mounths

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Bioavailability of hesperitin and naringenin in the blood, urine and feces
Tidsramme: 4 months
Quantification of hesperidin and naringenin and identification and quantification of their metabolites in the blood, urine and feces
4 months
Body mass index
Tidsramme: 4 months
4 months
Body lean mass
Tidsramme: 4 months
4 months
Body fat mass
Tidsramme: 4 months
4 months
% body fat
Tidsramme: 4 months
4 months
Ratio waist/hip
Tidsramme: 4 mounths
4 mounths
Glucose
Tidsramme: 4 mounths
4 mounths
Insulin
Tidsramme: 4 mounths
4 mounths
Total cholesterol
Tidsramme: 4 mounths
4 mounths
Low density lipoprotein cholesterol
Tidsramme: 4 mounths
4 mounths
High density lipoprotein cholesterol
Tidsramme: 4 mounths
4 mounths
Triglycerides
Tidsramme: 4 mounths
4 mounths
hsCRP
Tidsramme: 4 mounths
4 mounths
Alkaline phosphatase
Tidsramme: 4 mounths
4 mounths
Aspartate enzyme aminotransferase
Tidsramme: 4 mounths
4 mounths
Alanine enzyme aminotransferase
Tidsramme: 4 mounths
4 mounths
GammaGT
Tidsramme: 4 mounths
4 mounths
Glycemic curve
Tidsramme: 4 mounths
4 mounths
Insulin curve
Tidsramme: 4 mounths
4 mounths

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Thais B Cesar, PhD, São Paulo State University

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. september 2016

Primær færdiggørelse (Faktiske)

1. oktober 2016

Studieafslutning (Faktiske)

1. februar 2017

Datoer for studieregistrering

Først indsendt

6. januar 2017

Først indsendt, der opfyldte QC-kriterier

24. januar 2017

Først opslået (Skøn)

26. januar 2017

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

26. april 2017

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

25. april 2017

Sidst verificeret

1. april 2017

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • SaoPSU2

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

IPD-planbeskrivelse

There is still no decision regarding if the individual participant data (IPD) will be available to other researchers.

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner